Radiotherapy combined with ICRF 159 (NSC 129943).

Suppr

超能文献

作者信息

Rhomberg W U

出版信息

Int J Radiat Oncol Biol Phys. 1978 Jan-Feb;4(1-2):121-6. doi: 10.1016/0360-3016(78)90126-8.

DOI:10.1016/0360-3016(78)90126-8

PMID:204615

Abstract

摘要

相似文献

Radiotherapy combined with ICRF 159 (NSC 129943).

Int J Radiat Oncol Biol Phys. 1978 Jan-Feb;4(1-2):121-6. doi: 10.1016/0360-3016(78)90126-8.

A clinical evaluation of ICRF 159 as a radiosensitising agent.

Int J Radiat Oncol Biol Phys. 1978 Jan-Feb;4(1-2):127-31. doi: 10.1016/0360-3016(78)90127-x.

Radiotherapy and ICRF 159 in the treatment of soft tissue sarcomas.

Int J Radiat Oncol Biol Phys. 1978 Jan-Feb;4(1-2):133-4. doi: 10.1016/0360-3016(78)90128-1.

[Clinical experiences with radiotherapy and ICRF 159 in sarcomas].

Strahlentherapie Sonderb. 1978;75:110-4.

Preliminary report on AT1727 as a potential radiosensitizer.

Int J Radiat Oncol Biol Phys. 1984 Dec;10(12):2305-7. doi: 10.1016/0360-3016(84)90237-2.

Combination of radiation and razoxane (ICRF 159) in vivo.

Int J Radiat Oncol Biol Phys. 1978 Jan-Feb;4(1-2):109-13. doi: 10.1016/0360-3016(78)90124-4.

Radiotherapy vs. radiotherapy and razoxane in the treatment of soft tissue sarcomas: final results of a randomized study.

Int J Radiat Oncol Biol Phys. 1996 Dec 1;36(5):1077-84. doi: 10.1016/s0360-3016(96)00433-6.

Double blind controlled clinical trial of radiation plus razoxane (ICRF 159) versus radiation plus placebo in the treatment of head and neck cancer.

Int J Radiat Oncol Biol Phys. 1978 Jan-Feb;4(1-2):115-9. doi: 10.1016/0360-3016(78)90125-6.

Comparison of radiotherapy with and without razoxane (ICRF 159) in the treatment of soft tissue sarcomas.

Cancer. 1978 Jan;41(1):100-7. doi: 10.1002/1097-0142(197801)41:1<100::aid-cncr2820410115>3.0.co;2-p.

ICRF 159, (+/-) 1,2-di(3,5-dioxopiperazin-1-yl) propane NSC-129,943; razoxane.

Cancer Treat Rev. 1976 Jun;3(2):95-107. doi: 10.1016/s0305-7372(76)80007-2.

引用本文的文献

[Angiosarcoma of the right atrium: local control via low radiation doses and razoxane. A case report].

Strahlenther Onkol. 1999 Mar;175(3):102-4. doi: 10.1007/BF02742342.

Responses of liver metastases to radiotherapy and razoxane.

J R Soc Med. 1992 Mar;85(3):136-8.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Radiotherapy combined with ICRF 159 (NSC 129943).

Int J Radiat Oncol Biol Phys. 1978 Jan-Feb;4(1-2):121-6. doi: 10.1016/0360-3016(78)90126-8.

A clinical evaluation of ICRF 159 as a radiosensitising agent.

Int J Radiat Oncol Biol Phys. 1978 Jan-Feb;4(1-2):127-31. doi: 10.1016/0360-3016(78)90127-x.

Radiotherapy and ICRF 159 in the treatment of soft tissue sarcomas.

Int J Radiat Oncol Biol Phys. 1978 Jan-Feb;4(1-2):133-4. doi: 10.1016/0360-3016(78)90128-1.

[Clinical experiences with radiotherapy and ICRF 159 in sarcomas].

Strahlentherapie Sonderb. 1978;75:110-4.

Preliminary report on AT1727 as a potential radiosensitizer.

Int J Radiat Oncol Biol Phys. 1984 Dec;10(12):2305-7. doi: 10.1016/0360-3016(84)90237-2.

Combination of radiation and razoxane (ICRF 159) in vivo.

Int J Radiat Oncol Biol Phys. 1978 Jan-Feb;4(1-2):109-13. doi: 10.1016/0360-3016(78)90124-4.

Radiotherapy vs. radiotherapy and razoxane in the treatment of soft tissue sarcomas: final results of a randomized study.

Int J Radiat Oncol Biol Phys. 1996 Dec 1;36(5):1077-84. doi: 10.1016/s0360-3016(96)00433-6.

Double blind controlled clinical trial of radiation plus razoxane (ICRF 159) versus radiation plus placebo in the treatment of head and neck cancer.

Int J Radiat Oncol Biol Phys. 1978 Jan-Feb;4(1-2):115-9. doi: 10.1016/0360-3016(78)90125-6.

Comparison of radiotherapy with and without razoxane (ICRF 159) in the treatment of soft tissue sarcomas.

Cancer. 1978 Jan;41(1):100-7. doi: 10.1002/1097-0142(197801)41:1<100::aid-cncr2820410115>3.0.co;2-p.

ICRF 159, (+/-) 1,2-di(3,5-dioxopiperazin-1-yl) propane NSC-129,943; razoxane.

Cancer Treat Rev. 1976 Jun;3(2):95-107. doi: 10.1016/s0305-7372(76)80007-2.

引用本文的文献

[Angiosarcoma of the right atrium: local control via low radiation doses and razoxane. A case report].

Strahlenther Onkol. 1999 Mar;175(3):102-4. doi: 10.1007/BF02742342.

Responses of liver metastases to radiotherapy and razoxane.

J R Soc Med. 1992 Mar;85(3):136-8.